Loading...

Agilent Technologies

NYSE:A
Snowflake Description

Outstanding track record with flawless balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
A
NYSE
$22B
Market Cap
  1. Home
  2. US
  3. Pharmaceuticals & Biotech
Company description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The last earnings update was 9 days ago. More info.


Add to Portfolio Compare Print
A Share Price and Events
7 Day Returns
-1.9%
NYSE:A
0.1%
US Life Sciences
0.2%
US Market
1 Year Returns
6%
NYSE:A
17.9%
US Life Sciences
2.9%
US Market
A Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Agilent Technologies (A) -1.9% -10% -13.3% 6% 49.4% 19.3%
US Life Sciences 0.1% -1.5% -0.7% 17.9% 74.9% 104.9%
US Market 0.2% -1.6% 2.4% 2.9% 36.1% 41%
1 Year Return vs Industry and Market
  • A underperformed the Life Sciences industry which returned 17.9% over the past year.
  • A outperformed the Market in United States of America which returned 2.9% over the past year.
Price Volatility
A
Industry
5yr Volatility vs Market

A Value

 Is Agilent Technologies undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Agilent Technologies to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Agilent Technologies.

NYSE:A Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 12 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:A
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Life Sciences Unlevered Beta Simply Wall St/ S&P Global 1.02
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.015 (1 + (1- 21%) (8.34%))
1.055
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.05
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.055 * 5.96%)
9.02%

Discounted Cash Flow Calculation for NYSE:A using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Agilent Technologies is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NYSE:A DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 9.02%)
2019 989.00 Analyst x6 907.20
2020 1,127.60 Analyst x5 948.78
2021 1,184.50 Analyst x2 914.22
2022 1,235.04 Est @ 4.27% 874.38
2023 1,282.04 Est @ 3.81% 832.58
2024 1,326.69 Est @ 3.48% 790.32
2025 1,369.90 Est @ 3.26% 748.56
2026 1,412.36 Est @ 3.1% 707.92
2027 1,454.56 Est @ 2.99% 668.77
2028 1,496.90 Est @ 2.91% 631.32
Present value of next 10 years cash flows $8,024.06
NYSE:A DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $1,496.90 × (1 + 2.73%) ÷ (9.02% – 2.73%)
$24,459.02
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $24,459.02 ÷ (1 + 9.02%)10
$10,315.55
NYSE:A Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $8,024.06 + $10,315.55
$18,339.61
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $18,339.61 / 316.99
$57.86
NYSE:A Discount to Share Price
Calculation Result
Value per share (USD) From above. $57.86
Current discount Discount to share price of $67.97
= -1 x ($67.97 - $57.86) / $57.86
-17.5%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Agilent Technologies is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Agilent Technologies's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Agilent Technologies's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:A PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-04-30) in USD $3.51
NYSE:A Share Price ** NYSE (2019-05-22) in USD $67.97
United States of America Life Sciences Industry PE Ratio Median Figure of 21 Publicly-Listed Life Sciences Companies 33.81x
United States of America Market PE Ratio Median Figure of 3,085 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Agilent Technologies.

NYSE:A PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:A Share Price ÷ EPS (both in USD)

= 67.97 ÷ 3.51

19.38x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Agilent Technologies is good value based on earnings compared to the US Life Sciences industry average.
  • Agilent Technologies is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Agilent Technologies's expected growth come at a high price?
Raw Data
NYSE:A PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 19.38x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts
-4%per year
United States of America Life Sciences Industry PEG Ratio Median Figure of 19 Publicly-Listed Life Sciences Companies 2.38x
United States of America Market PEG Ratio Median Figure of 2,123 Publicly-Listed Companies 1.54x

*Line of best fit is calculated by linear regression .

NYSE:A PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 19.38x ÷ -4%

-4.86x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Agilent Technologies earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Agilent Technologies's assets?
Raw Data
NYSE:A PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-04-30) in USD $16.17
NYSE:A Share Price * NYSE (2019-05-22) in USD $67.97
United States of America Life Sciences Industry PB Ratio Median Figure of 38 Publicly-Listed Life Sciences Companies 4.52x
United States of America Market PB Ratio Median Figure of 5,201 Publicly-Listed Companies 1.84x
NYSE:A PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:A Share Price ÷ Book Value per Share (both in USD)

= 67.97 ÷ 16.17

4.2x

* Primary Listing of Agilent Technologies.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Agilent Technologies is good value based on assets compared to the US Life Sciences industry average.
X
Value checks
We assess Agilent Technologies's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Life Sciences industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Life Sciences industry average (and greater than 0)? (1 check)
  5. Agilent Technologies has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

A Future Performance

 How is Agilent Technologies expected to perform in the next 1 to 3 years based on estimates from 12 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Agilent Technologies expected to grow at an attractive rate?
  • Agilent Technologies's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Agilent Technologies's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.
  • Agilent Technologies's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:A Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:A Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts -4%
NYSE:A Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 12 Analysts 5.8%
United States of America Life Sciences Industry Earnings Growth Rate Market Cap Weighted Average 14.4%
United States of America Life Sciences Industry Revenue Growth Rate Market Cap Weighted Average 7.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.7%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:A Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 weeks ago) See Below
Future Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:A Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-10-31 6,417 1
2022-10-31 6,077 1
2021-10-31 5,767 1,317 1,059 8
2020-10-31 5,428 1,237 958 12
2019-10-31 5,105 1,087 1,126 12
NYSE:A Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-04-30 5,019 1,034 1,117
2019-01-31 4,987 1,085 1,140
2018-10-31 4,914 1,087 316
2018-07-31 4,809 1,003 298
2018-04-30 4,720 1,034 237
2018-01-31 4,616 988 196
2017-10-31 4,472 889 684
2017-07-31 4,394 835 633
2017-04-30 4,324 801 582
2017-01-31 4,241 798 509
2016-10-31 4,202 793 462
2016-07-31 4,126 800 476

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Agilent Technologies's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Agilent Technologies's revenue is expected to grow by 5.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:A Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 weeks ago) See Below
Future Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below

All data from Agilent Technologies Company Filings, last reported 3 weeks ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:A Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-10-31
2022-10-31
2021-10-31 3.38 3.48 3.18 3.00
2020-10-31 3.08 3.27 2.86 5.00
2019-10-31 3.56 3.67 3.49 5.00
NYSE:A Past Financials Data
Date (Data in USD Millions) EPS *
2019-04-30 3.51
2019-01-31 3.57
2018-10-31 0.98
2018-07-31 0.93
2018-04-30 0.74
2018-01-31 0.61
2017-10-31 2.12
2017-07-31 1.96
2017-04-30 1.80
2017-01-31 1.57
2016-10-31 1.42
2016-07-31 1.46

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Agilent Technologies is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Agilent Technologies's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Agilent Technologies has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

A Past Performance

  How has Agilent Technologies performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Agilent Technologies's growth in the last year to its industry (Life Sciences).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Agilent Technologies's year on year earnings growth rate has been positive over the past 5 years.
  • Agilent Technologies's 1-year earnings growth exceeds its 5-year average (371.3% vs 15.9%)
  • Agilent Technologies's earnings growth has exceeded the US Life Sciences industry average in the past year (371.3% vs 45.3%).
Earnings and Revenue History
Agilent Technologies's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Agilent Technologies Company Filings, last reported 3 weeks ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:A Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-04-30 5,019.00 1,117.00 1,349.00 400.00
2019-01-31 4,987.00 1,140.00 1,343.00 393.00
2018-10-31 4,914.00 316.00 1,328.00 385.00
2018-07-31 4,809.00 298.00 1,285.00 371.00
2018-04-30 4,720.00 237.00 1,263.00 361.00
2018-01-31 4,616.00 196.00 1,235.00 354.00
2017-10-31 4,472.00 684.00 1,187.00 339.00
2017-07-31 4,394.00 633.00 1,173.00 330.00
2017-04-30 4,324.00 582.00 1,167.00 329.00
2017-01-31 4,241.00 509.00 1,159.00 326.00
2016-10-31 4,202.00 462.00 1,174.00 325.00
2016-07-31 4,126.00 476.00 1,184.00 324.00
2016-04-30 4,096.00 465.00 1,175.00 317.00
2016-01-31 4,040.00 466.00 1,170.00 317.00
2015-10-31 4,038.00 438.00 1,189.00 327.00
2015-07-31 4,046.00 306.00 1,189.00 340.00
2015-04-30 4,041.00 256.00 1,184.00 347.00
2015-01-31 4,066.00 204.00 1,196.00 353.00
2014-10-31 4,048.00 232.00 1,199.00 358.00
2014-07-31 4,723.00 435.00 1,325.00 434.00
2014-04-30 5,366.00 540.00 1,490.00 518.00
2014-01-31 6,110.00 666.00 1,654.00 604.00
2013-10-31 3,894.00 225.00 1,184.00 337.00
2013-07-31 6,831.00 938.00 1,866.00 700.00
2013-04-30 6,902.00 1,013.00 1,861.00 692.00
2013-01-31 6,903.00 1,102.00 1,845.00 685.00
2012-10-31 6,858.00 1,153.00 1,802.00 668.00
2012-07-31 6,819.00 1,017.00 1,781.00 653.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Agilent Technologies has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • Agilent Technologies used its assets more efficiently than the US Life Sciences industry average last year based on Return on Assets.
  • Agilent Technologies has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Agilent Technologies's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Life Sciences industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Agilent Technologies has a total score of 6/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

A Health

 How is Agilent Technologies's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Agilent Technologies's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Agilent Technologies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Agilent Technologies's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Agilent Technologies's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Agilent Technologies Company Filings, last reported 3 weeks ago.

NYSE:A Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-04-30 5,125.00 1,798.00 2,155.00
2019-01-31 5,036.00 1,798.00 2,057.00
2018-10-31 4,571.00 1,799.00 2,247.00
2018-07-31 4,568.00 1,799.00 2,131.00
2018-04-30 4,617.00 2,115.00 3,011.00
2018-01-31 4,526.00 2,145.00 2,887.00
2017-10-31 4,835.00 2,011.00 2,678.00
2017-07-31 4,611.00 2,081.00 2,563.00
2017-04-30 4,375.00 2,043.00 2,389.00
2017-01-31 4,300.00 1,992.00 2,241.00
2016-10-31 4,246.00 1,904.00 2,289.00
2016-07-31 4,346.00 1,901.00 2,199.00
2016-04-30 4,165.00 1,892.00 2,139.00
2016-01-31 4,048.00 1,733.00 1,931.00
2015-10-31 4,170.00 1,655.00 2,003.00
2015-07-31 4,106.00 1,655.00 2,075.00
2015-04-30 4,161.00 1,656.00 2,197.00
2015-01-31 4,240.00 1,658.00 2,118.00
2014-10-31 5,304.00 1,663.00 2,218.00
2014-07-31 5,640.00 2,216.00 2,391.00
2014-04-30 5,629.00 2,693.00 2,950.00
2014-01-31 5,447.00 2,695.00 2,742.00
2013-10-31 5,289.00 2,699.00 2,675.00
2013-07-31 4,790.00 2,701.00 2,330.00
2013-04-30 5,308.00 2,356.00 2,519.00
2013-01-31 5,351.00 2,361.00 2,450.00
2012-10-31 5,185.00 2,362.00 2,362.00
2012-07-31 4,873.00 2,214.00 1,923.00
  • Agilent Technologies's level of debt (35.1%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (47.7% vs 35.1% today).
  • Debt is well covered by operating cash flow (57.5%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 31.3x coverage).
X
Financial health checks
We assess Agilent Technologies's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Agilent Technologies has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

A Dividends

 What is Agilent Technologies's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.97%
Current annual income from Agilent Technologies dividends. Estimated to be 1.05% next year.
If you bought $2,000 of Agilent Technologies shares you are expected to receive $19 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Agilent Technologies's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).
  • Agilent Technologies's dividend is below the markets top 25% of dividend payers in United States of America (3.7%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:A Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below
United States of America Life Sciences Industry Average Dividend Yield Market Cap Weighted Average of 7 Stocks 0.4%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2005 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:A Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-10-31
2022-10-31
2021-10-31 0.79 5.00
2020-10-31 0.72 8.00
2019-10-31 0.66 8.00
NYSE:A Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-03-20 0.656 0.850
2018-11-14 0.656 0.906
2018-09-19 0.596 0.891
2018-05-16 0.596 0.919
2018-03-21 0.596 0.894
2017-11-15 0.596 0.858
2017-09-20 0.528 0.792
2017-05-17 0.528 0.867
2017-03-15 0.528 0.975
2016-11-17 0.528 1.100
2016-09-21 0.460 1.008
2015-09-16 0.400 0.979
2015-05-20 0.400 1.025
2015-03-18 0.400 0.948
2014-11-20 0.400 0.986
2014-09-17 0.528 1.055
2014-05-22 0.528 0.922
2014-04-01 0.528 0.963
2013-11-22 0.528 0.929
2013-09-18 0.480 0.930
2013-05-23 0.480 1.049
2013-01-17 0.480 1.115
2012-11-16 0.400 1.000
2012-09-20 0.400 1.069
2012-05-16 0.400 1.036
2012-01-18 0.400 0.930

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Agilent Technologies has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but Agilent Technologies only paid a dividend in the past 7 years.
Current Payout to shareholders
What portion of Agilent Technologies's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (5.6x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (5.2x coverage).
X
Income/ dividend checks
We assess Agilent Technologies's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Agilent Technologies afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Agilent Technologies has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

A Management

 What is the CEO of Agilent Technologies's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mike McMullen
COMPENSATION $11,708,230
AGE 57
TENURE AS CEO 4.2 years
CEO Bio

Mr. Michael R. McMullen, also known as Mike, has been the President of Agilent Technologies, Inc., since September 17, 2014 and Chief Executive Officer since March 18, 2015. Mr. McMullen has been a Director of Agilent Technologies, Inc. since March 2015. He has industry experience and senior management experience at Agilent. Mr. McMullen served as Senior Vice President and President of the Chemical Analysis Group at Agilent Technologies Inc., since September 2009 until September 17, 2014 and Chief Operating Officer from September 17, 2014 to March 2015. He served as Vice President and General Manager of Chemical Analysis Solutions Unit- Life Sciences and Chemical Analysis (LSCA) of Agilent Technologies Inc., from January 2002 to September 2009. Prior to that, Mr. McMullen served as Controller for the Hewlett Packard Company and Yokogawa Electric Joint Venture from July 1996 to March 1999. Mr. McMullen joined Hewlett-Packard Company in 1984 as a Financial Analyst and has held several management and senior management positions for 19 years. Mr. McMullen also worked at Agilent’s joint venture, Yokogawa Analytical Systems. He has been Director of Coherent, Inc. since September 28, 2018. His various assignments while in Japan included entity Controller. Prior to assuming this position, from March 1999 to December 2001, Mr. McMullen served as Country Manager for Agilent’s China, Japan and Korea Life Sciences and Chemical Analysis Group. Mr. McMullen has been a Member of the Board of Directors of Agilent since March 2015. Mr. McMullen’s years of executive and management experience in the high technology industry, including serving as the Chief Executive Officer and on the Board of another publicly held company make him an invaluable Member of the Board. Mr. McMullen holds a Bachelor’s Degree in Economics and Business Administration from the University of Delaware and an MBA from Wharton Business School.

CEO Compensation
  • Mike's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Mike's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Agilent Technologies management team in years:

4.1
Average Tenure
54.5
Average Age
  • The tenure for the Agilent Technologies management team is about average.
Management Team

Mike McMullen

TITLE
CEO, President & Director
COMPENSATION
$12M
AGE
57
TENURE
4.2 yrs

Bob McMahon

TITLE
Senior VP & CFO
COMPENSATION
$7M
AGE
49
TENURE
0.7 yrs

Dominique Grau

TITLE
Senior Vice President of Human Resources
COMPENSATION
$2M
AGE
59
TENURE
4.8 yrs

Mark Doak

TITLE
Senior Vice President
COMPENSATION
$3M
AGE
63
TENURE
4.7 yrs

Jacob Thaysen

TITLE
Senior Vice President
COMPENSATION
$3M
AGE
43

Rodney Gonsalves

TITLE
Chief Accounting Officer
AGE
52
TENURE
4 yrs

Darlene J. Solomon

TITLE
CTO & Senior VP
AGE
59
TENURE
15.7 yrs

Ankur Dhingra

TITLE
Vice President of Investor Relations

Michael Tang

TITLE
Senior VP
AGE
44
TENURE
3.3 yrs

Eric Gerber

TITLE
Senior Vice President of Strategy & Corporate Development
TENURE
0.5 yrs
Board of Directors Tenure

Average tenure and age of the Agilent Technologies board of directors in years:

4
Average Tenure
64
Average Age
  • The tenure for the Agilent Technologies board of directors is about average.
Board of Directors

Boon Hwee Koh

TITLE
Non-Executive Chairman
COMPENSATION
$449K
AGE
67
TENURE
2.2 yrs

Mike McMullen

TITLE
CEO, President & Director
COMPENSATION
$12M
AGE
57
TENURE
4.2 yrs

Paul Clark

TITLE
Non-Executive Director
COMPENSATION
$319K
AGE
71
TENURE
13 yrs

Tadataka Yamada

TITLE
Director
COMPENSATION
$314K
AGE
72
TENURE
8.3 yrs

Heidi Fields

TITLE
Director
COMPENSATION
$294K
AGE
63
TENURE
19.3 yrs

George Scangos

TITLE
Director
COMPENSATION
$294K
AGE
70
TENURE
4.7 yrs

Dan Podolsky

TITLE
Director
COMPENSATION
$304K
AGE
65
TENURE
3.8 yrs

Sue Rataj

TITLE
Director
COMPENSATION
$304K
AGE
61
TENURE
3.7 yrs

Hans Bishop

TITLE
Director
COMPENSATION
$261K
AGE
54
TENURE
1.8 yrs

Dow Wilson

TITLE
Director
COMPENSATION
$271K
AGE
59
TENURE
1.2 yrs
Who owns this company?
Recent Insider Trading
  • Agilent Technologies insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
27. Mar 19 Sell Paul Clark Individual 27. Mar 19 27. Mar 19 -2,823 $80.31 $-226,715
08. Mar 19 Sell Rodney Gonsalves Individual 06. Mar 19 06. Mar 19 -1,155 $79.79 $-92,157
25. Feb 19 Sell Mark Doak Individual 22. Feb 19 22. Feb 19 -4,000 $77.95 $-311,800
29. Nov 18 Sell Rodney Gonsalves Individual 28. Nov 18 28. Nov 18 -1,500 $71.06 $-106,590
14. Sep 18 Sell Paul Clark Individual 13. Sep 18 13. Sep 18 -2,876 $68.60 $-197,294
X
Management checks
We assess Agilent Technologies's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Agilent Technologies has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

A News

Simply Wall St News

Why Dividend Hunters Love Agilent Technologies, Inc. (NYSE:A)

Investors might not know much about Agilent Technologies's dividend prospects, even though it has been paying dividends for the last seven years and offers a 1.0% yield. … Looking at the data, we can see that Agilent Technologies has been paying a dividend for the past seven years. … Conclusion To summarise, shareholders should always check that Agilent Technologies's dividends are affordable, that its dividend payments are relatively stable, and that it has decent prospects for growing its earnings and dividend.

Simply Wall St -

Does The Data Make Agilent Technologies, Inc. (NYSE:A) An Attractive Investment?

NYSE:A Income Statement, May 10th 2019 Next Steps: For Agilent Technologies, there are three essential factors you should further research: Future Outlook: What are well-informed industry analysts predicting for A’s future growth? … Take a look at our free research report of analyst consensus for A’s outlook. … The intrinsic value infographic in our free research report helps visualize whether A is currently mispriced by the market.

Simply Wall St -

Is Agilent Technologies, Inc. (NYSE:A) Worth US$77.33 Based On Its Intrinsic Value?

by taking the expected future cash flows and discounting them to their present value. … We generally believe that a company's value is the present value of all of the cash it will generate in the future. … If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model

Simply Wall St -

Here's Why I Think Agilent Technologies (NYSE:A) Is An Interesting Stock

In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like Agilent Technologies (NYSE:A). … I like to take a look at earnings before interest and (EBIT) tax margins, as well as revenue growth, to get another take on the quality of the company's growth. … You can take a look at the company's revenue and earnings growth trend, in the chart below

Simply Wall St -

Why Agilent Technologies, Inc. (NYSE:A) Looks Like A Quality Company

With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. … One way to conceptualize this, is that for each $1 of shareholders' equity it has, the company made $0.23 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Is Agilent Technologies, Inc. (NYSE:A) As Strong As Its Balance Sheet Indicates?

Most investors favour these big stocks due to their strong balance sheet and high market liquidity, meaning there are an abundance of stock in the public market available for trading. … These companies are resilient in times of low liquidity and are not as strongly impacted by interest rate hikes as companies with lots of debt. … Today I will analyse the latest financial data for A to determine is solvency and liquidity and whether the stock is a sound investment.

Simply Wall St -

Should You Think About Buying Agilent Technologies, Inc. (NYSE:A) Now?

received a lot of attention from a substantial price increase on the NYSE over the last few months. … As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock … However, could the stock still be trading at a relatively cheap price?

Simply Wall St -

Our Take On Agilent Technologies, Inc.'s (NYSE:A) CEO Salary

First, this article will compare CEO compensation with compensation at other large companies. … How Does Mike McMullen's Compensation Compare With Similar Sized Companies. … is worth US$25b, and total annual CEO compensation is US$12m.

Simply Wall St -

What Does Agilent Technologies, Inc.'s (NYSE:A) P/E Ratio Tell You?

To keep it practical, we'll show how Agilent Technologies, Inc.'s (NYSE:A) P/E ratio could help you assess the value on offer. … How Do I Calculate Agilent Technologies's Price To Earnings Ratio … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

What Kind Of Shareholders Own Agilent Technologies, Inc. (NYSE:A)?

Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … Agilent Technologies is a pretty big company. … View our latest analysis for Agilent Technologies

Simply Wall St -

A Company Info

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.

Details
Name: Agilent Technologies, Inc.
A
Exchange: NYSE
Founded: 1999
$21,545,878,270
316,991,000
Website: http://www.agilent.com
Address: Agilent Technologies, Inc.
5301 Stevens Creek Boulevard,
Santa Clara,
California, 95051,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE A Common Stock New York Stock Exchange US USD 18. Nov 1999
DB AG8 Common Stock Deutsche Boerse AG DE EUR 18. Nov 1999
LSE 0HAV Common Stock London Stock Exchange GB USD 18. Nov 1999
BMV A * Common Stock Bolsa Mexicana de Valores MX MXN 18. Nov 1999
Number of employees
Current staff
Staff numbers
15,550
Agilent Technologies employees.
Industry
Life Sciences Tools and Services
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/23 03:38
End of day share price update: 2019/05/22 00:00
Last estimates confirmation: 2019/05/16
Last earnings filing: 2019/05/14
Last earnings reported: 2019/04/30
Last annual earnings reported: 2018/10/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.